UniSa - IRIS Institutional Research Information System

Charlier, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.078
NA - Nord America 1.689
EU - Europa 827
SA - Sud America 151
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 24
OC - Oceania 8
Totale 5.844
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 2.267
US - Stati Uniti d'America 1.635
IT - Italia 410
SG - Singapore 366
CN - Cina 149
RU - Federazione Russa 127
VN - Vietnam 111
BR - Brasile 100
DE - Germania 61
FR - Francia 53
BD - Bangladesh 49
GB - Regno Unito 48
IN - India 38
CA - Canada 26
IE - Irlanda 20
FI - Finlandia 19
AR - Argentina 17
KR - Corea 17
PL - Polonia 17
MX - Messico 15
ES - Italia 14
SE - Svezia 13
JP - Giappone 11
EC - Ecuador 10
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 9
TR - Turchia 9
AT - Austria 8
AU - Australia 8
SA - Arabia Saudita 8
UA - Ucraina 8
ZA - Sudafrica 7
BE - Belgio 5
UY - Uruguay 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
SY - Repubblica araba siriana 4
CL - Cile 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
VE - Venezuela 3
DZ - Algeria 2
GY - Guiana 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 5.778
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.258
San Jose 263
Singapore 202
Dallas 156
Ashburn 135
Chandler 93
Milan 77
Council Bluffs 71
New York 55
Naples 54
Princeton 50
Munich 47
Ann Arbor 45
Beijing 43
Rome 37
Los Angeles 36
Ho Chi Minh City 34
Santa Clara 30
Lauterbourg 27
Hanoi 22
Salerno 21
Dublin 20
Phoenix 19
Memphis 18
Dong Ket 17
The Dalles 17
Woodbridge 16
Moscow 14
Redwood City 14
São Paulo 14
Warsaw 14
Jacksonville 13
Mercato San Severino 13
Orem 13
Pune 13
Turku 13
Wokingham 13
Stockholm 12
Fisciano 11
Seattle 11
San Antonio 10
Buffalo 9
Denver 9
Chennai 8
Houston 8
Montreal 8
Tokyo 8
Wilmington 8
Amsterdam 7
Brooklyn 7
Chicago 7
London 7
San Francisco 7
Arba 6
Atlanta 6
Boardman 6
Boston 6
Montpellier 6
San Prisco 6
Adelaide 5
Francavilla Fontana 5
Guangzhou 5
Haiphong 5
Izmir 5
Johannesburg 5
Montevideo 5
Nuremberg 5
Palermo 5
Richmond 5
Seoul 5
Tianjin 5
Toronto 5
Valencia 5
Andover 4
Aversa 4
Brasília 4
Figino 4
Glasgow 4
Guayaquil 4
Helsinki 4
Mexico City 4
Mumbai 4
Nairobi 4
Norwalk 4
Ottawa 4
Quito 4
Rio de Janeiro 4
Shanghai 4
The Bronx 4
Verona 4
Biên Hòa 3
Bologna 3
Caserta 3
Fairfield 3
Hebei 3
Huntington 3
Jakarta 3
Madrid 3
Manchester 3
Medina 3
Totale 4.338
Salva come PNG Salva come JPEG
Nome #
A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers 807
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 607
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1 435
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 285
Come rendere un ospedale formaldeide free 240
In Vitro Evaluation of Antibacterial and Antibiofilm Activity of Different Chlorhexidine-Containing Mouthwash Formulations against Streptococcus mutans 229
Standard addition method (SAM) in LC-MS/MS to quantify gluten-derived metabolites in urine samples 214
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 203
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 196
Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects 156
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease 149
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy 145
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples 141
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 137
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples 136
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood 135
Environmental and biological monitoring of formaldehyde inside a hospital setting: a combined approach to manage chemical risk in workplaces 132
Novel Drug Targets for the Treatment of Cardiac Diseases 127
Perampanel dosage in plasma samples: development and validation of a novel HPLC method with combined UV-Fluorescence detection 127
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 126
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 125
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents 115
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications 109
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 106
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 105
Bioconversion of 4-hydroxyestradiol by extradiol ring-cleavage dioxygenases from Novosphingobium sp. PP1Y 103
Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture 102
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry 93
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain 92
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 75
Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex 35
Catecholamines and Metanephrines: Quantification in the Diagnosis of Pheochromocytoma and Paraganglioma, Considerations and Critical Issues 27
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications 20
Development, validation and real life applicability of new bioanalytical methods in the assessment and prevention of chemical risk in healthcare environments 10
Totale 5.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 3 6 5 3 6 5 6 12 38
2022/2023249 15 33 37 32 17 40 6 18 30 0 6 15
2023/2024191 20 17 9 13 23 38 11 12 4 8 15 21
2024/2025536 4 12 9 16 37 42 121 30 77 23 67 98
2025/20264.004 138 1.359 1.036 185 233 74 236 77 145 245 98 178
2026/2027476 153 67 184 72 0 0 0 0 0 0 0 0
Totale 5.844